An Engineered Probiotic Produces a Type III Interferon IFNL1 and Reduces Inflammations in <i>in vitro</i> Inflammatory Bowel Disease Models
Koon Jiew Chua, Hua Ling, In Young Hwang, Hui Ling Lee, John C. March, Yung Seng Lee, Matthew Wook Chang
Abstract
IBD models, demonstrating their potential as live biotherapeutics for IBD immunotherapy.
Topics & Concepts
Inflammatory bowel diseaseInflammationFOXP3ImmunologyCytokineInterferonProinflammatory cytokineProbioticBiologyMedicineImmune systemDiseasePathologyGeneticsBacteriaInflammatory Bowel DiseaseGut microbiota and healthImmune cells in cancer